Cargando…
Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer
Esophageal cancer (EC) is a fatal digestive disease with a poor prognosis and frequent lymphatic metastases. Nevertheless, reliable biomarkers for EC diagnosis are currently unavailable. Accordingly, we have performed a comparative proteomics analysis on cancer and paracancer tissue-derived exosomes...
Autores principales: | Rao, Dingyu, Lu, Hua, Wang, Xiongwei, Lai, Zhonghong, Zhang, Jiali, Shen, Haibin, Huang, Defa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651172/ https://www.ncbi.nlm.nih.gov/pubmed/37966470 http://dx.doi.org/10.7554/eLife.86209 |
Ejemplares similares
-
Role of exosomes in the development, diagnosis, prognosis and treatment of hepatocellular carcinoma
por: Liu, Meijin, et al.
Publicado: (2023) -
Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients
por: Panigrahi, Gati K., et al.
Publicado: (2019) -
Tissue‐based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma
por: Cai, Xu‐Wei, et al.
Publicado: (2018) -
Role of CD147 in the development and diagnosis of hepatocellular carcinoma
por: Huang, Defa, et al.
Publicado: (2023) -
Identification and validation of circulating exosomes‐based liquid biopsy for esophageal cancer
por: Zhao, An, et al.
Publicado: (2019)